Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Henry Ford Hospital Replaces Heart Valve Outside the Heart

August 13, 2014 10:31 am | by PR Newswire | News | Comments

DETROIT, Aug. 13, 2014 /PRNewswire/ -- For the first time in the United States, doctors at Henry Ford Hospital used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one – and placed it just outside the heart. Due to prior medical...

DSM Expands Its Biomedical Business with the Launch of Its Cellular Therapy Development Services

August 13, 2014 10:30 am | by The Associated Press | News | Comments

EXTON, Pa.--(BUSINESS WIRE)--Aug 13, 2014-- DSM , a global leader in materials science and regenerative medicine, announced today the launch of its cellular therapy development services. Cellular therapies use a patient’s own cells to improve healing of an injury or disease. DSM develops products...

Tattoo biobatteries produce power from sweat

August 13, 2014 10:05 am | by EurekAlert! | News | Comments

In the future, working up a sweat by exercising may not only be good for your health, but it could also power your small electronic devices. Researchers will report today that they have designed a sensor in the form of a temporary tattoo that can both monitor a person's progress during exercise and produce power from their perspiration.

Advertisement

Exactech Announces First Implantation of New Alteon Tapered Wedge Femoral Stem

August 13, 2014 8:31 am | by The Associated Press | News | Comments

GAINESVILLE, Fla.--(BUSINESS WIRE)--Aug 13, 2014--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, is proud to announce the first implantation of the Alteon™ Tapered Wedge Femoral Stem. The surgery...

VolitionRx Invests in Laboratory Automation System to Increase Throughput Capacity for Large Clinical Trials

August 13, 2014 7:31 am | by PR Newswire | News | Comments

NAMUR, Belgium, Aug. 13, 2014 /PRNewswire/ -- VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announced it has installed a Tecan EVO200 automated liquid handling system in its Namur,...

Programmable Rotary Encoder

August 13, 2014 12:29 am | by MDT Staff | Product Releases | Comments

Newall's new RPE-PV programmable rotary encoder features a dynamic encoder resolution capability that allows users to easily program the resolution anywhere between 1 and 10,000 counts per revolution...

256-Channel, 24-Bit Current-to-Digital Converter Module

August 13, 2014 12:20 am | by MDT Staff | Analog Devices, Inc. | Product Releases | Comments

Analog Devices introduced a current-to-digital converter module that reduces the cost and complexity of computed tomography (CT) scanner system design...

Covaris Introduces microTUBE LV for Ultra-Low Volume DNA Shearing

August 12, 2014 5:27 pm | by PR Newswire | News | Comments

WOBURN, Mass., Aug. 12, 2014 /PRNewswire/ -- Covaris, Inc. announced the introduction of the patent-pending microTUBE LV, its latest product designed for low volume, high performance DNA Shearing for Next Generation Sequencing (NGS) applications.  The Covaris microTUBE LV allows...

Advertisement

New biomaterial coats tricky burn wounds by acting like cling wrap

August 12, 2014 3:17 pm | by American Chemical Society | News | Comments

Wrapping wound dressings around fingers and toes can be tricky, but for burn victims, guarding them against infection is critical. Today, scientists are reporting the development of novel, ultra-thin coatings called nanosheets that can ...

TOPICS:

23andMe announces agreement with Pfizer to research inflammatory bowel disease

August 12, 2014 3:06 pm | by EurekAlert! | News | Comments

23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD.

TOPICS:

R&D Magazine Announces Scientist and Innovator of the Year Award Winners

August 12, 2014 2:42 pm | by Lindsay Hock, Managing Editor, R&D Magazine | News | Comments

R&D Magazine today introduced its annual Scientist of the Year Award winner, Dr. Karl Deisseroth, and its Innovator of the Year Award winner, Dr. Hugh Herr. As R&D Magazine's 49th Scientist of the Year Award winner, Dr. Deisseroth is a leading researcher in the rapidly growing field of optogenetics, having invented ...

From eons to seconds, proteins exploit the same forces

August 12, 2014 2:36 pm | by Mike Williams, Rice University | News | Comments

Nature's artistic and engineering skills are evident in proteins, life's robust molecular machines. Scientists at Rice Univ. have now employed their unique theories to show how the interplay between evolution and physics developed these skills. A Rice team led by biophysicists ...

A highly sensitive microsphere-based assay for early detection of Type I diabetes

August 12, 2014 2:24 pm | by EurekAlert! | News | Comments

A team of researchers from the Center for Engineering in Medicine at the Massachusetts General Hospital have developed a novel fluorescence-based assay for sensitive detection of antibodies within microliter volume serum samples. This new assay is at least 50 times more sensitive than the traditional radioimmunoassay (RIA), which is the gold standard currently used in the clinic. This new technology is ...

Synthetic molecule makes cancer self-destruct

August 12, 2014 1:40 pm | by The University of Texas at Austin | News | Comments

Researchers from The University of Texas at Austin and five other institutions have created a molecule that can cause cancer cells to self-destruct by ferrying sodium and chloride ions into the cancer cells. These synthetic ion transporters, described this week...

Medical device company staffers admit to fraud

August 12, 2014 12:30 pm | by The Associated Press | News | Comments

Federal prosecutors say two staffers at a northern New Jersey medical devices firm have admitted their roles in a scheme to defraud hospitals out of more than $800,000. Daniel Metz, a 34-year-old Fairfield resident, and 35-year-old Charles Carey Jr., of Clark, both pleaded guilty Tuesday to...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading